Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.

Suchindran S, Rivedal D, Guyton JR, Milledge T, Gao X, Benjamin A, Rowell J, Ginsburg GS, McCarthy JJ.

PLoS Genet. 2010 Apr 29;6(4):e1000928. doi: 10.1371/journal.pgen.1000928.

2.

Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.

Chu AY, Guilianini F, Grallert H, Dupuis J, Ballantyne CM, Barratt BJ, Nyberg F, Chasman DI, Ridker PM.

Circ Cardiovasc Genet. 2012 Dec;5(6):676-85. doi: 10.1161/CIRCGENETICS.112.963314. Epub 2012 Nov 1.

PMID:
23118302
3.

Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study.

Schnabel R, Dupuis J, Larson MG, Lunetta KL, Robins SJ, Zhu Y, Rong J, Yin X, Stirnadel HA, Nelson JJ, Wilson PW, Keaney JF, Vasan RS, Benjamin EJ.

Atherosclerosis. 2009 Jun;204(2):601-7. doi: 10.1016/j.atherosclerosis.2008.10.030. Epub 2008 Nov 5.

4.

Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.

Grallert H, Dupuis J, Bis JC, Dehghan A, Barbalic M, Baumert J, Lu C, Smith NL, Uitterlinden AG, Roberts R, Khuseyinova N, Schnabel RB, Rice KM, Rivadeneira F, Hoogeveen RC, Fontes JD, Meisinger C, Keaney JF Jr, Lemaitre R, Aulchenko YS, Vasan RS, Ellis S, Hazen SL, van Duijn CM, Nelson JJ, März W, Schunkert H, McPherson RM, Stirnadel-Farrant HA, Psaty BM, Gieger C, Siscovick D, Hofman A, Illig T, Cushman M, Yamamoto JF, Rotter JI, Larson MG, Stewart AF, Boerwinkle E, Witteman JC, Tracy RP, Koenig W, Benjamin EJ, Ballantyne CM.

Eur Heart J. 2012 Jan;33(2):238-51. doi: 10.1093/eurheartj/ehr372. Epub 2011 Oct 14.

5.

[Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].

Jia ZR, Zhao D, Qi Y, Wang W, Wang M, Sun JY, Qin LP, Liu J.

Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Nov;41(11):962-7. Chinese.

PMID:
24370228
6.

Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.

Onat A, Hergenç G, Can G, Uğur M, Nartop F.

Clin Chem Lab Med. 2011 Aug;49(8):1349-57. doi: 10.1515/CCLM.2011.110. Epub 2011 Jul 14.

PMID:
21756164
7.

Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study.

Hou L, Chen S, Yu H, Lu X, Chen J, Wang L, Huang J, Fan Z, Gu D.

Hum Genet. 2009 Feb;125(1):11-20. doi: 10.1007/s00439-008-0587-4. Epub 2008 Nov 26.

PMID:
19034521
8.

Effects of V279F in the Lp-PLA(2) gene on markers of oxidative stress and inflammation in Koreans.

Paik JK, Chae JS, Jang Y, Kim JY, Kim OY, Jeong TS, Lee SH, Lee JH.

Clin Chim Acta. 2010 Apr 2;411(7-8):486-93. doi: 10.1016/j.cca.2009.12.021. Epub 2010 Jan 18.

PMID:
20080080
9.

Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosis.

Ferguson JF, Hinkle CC, Mehta NN, Bagheri R, Derohannessian SL, Shah R, Mucksavage MI, Bradfield JP, Hakonarson H, Wang X, Master SR, Rader DJ, Li M, Reilly MP.

J Am Coll Cardiol. 2012 Feb 21;59(8):764-72. doi: 10.1016/j.jacc.2011.11.019.

10.

The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men.

Jang Y, Kim OY, Koh SJ, Chae JS, Ko YG, Kim JY, Cho H, Jeong TS, Lee WS, Ordovas JM, Lee JH.

J Clin Endocrinol Metab. 2006 Sep;91(9):3521-7. Epub 2006 Jun 20.

PMID:
16787988
11.

Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature.

Gregson J, Stirnadel-Farrant HA, Doobaree IU, Koro C.

Atherosclerosis. 2012 Nov;225(1):11-21. doi: 10.1016/j.atherosclerosis.2012.06.020. Epub 2012 Jun 21. Review.

PMID:
22784637
12.

Association of lipoprotein-associated phospholipase A₂ activity with components of the metabolic syndrome in apparently healthy boys.

Hirschler V, Meroño T, Maccallini G, Gomez Rosso L, Aranda C, Brites F.

Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):78-83.

PMID:
21476960
13.

A pleiotropic QTL on 2p influences serum Lp-PLA2 activity and LDL cholesterol concentration in a baboon model for the genetics of atherosclerosis risk factors.

Vinson A, Mahaney MC, Cox LA, Rogers J, VandeBerg JL, Rainwater DL.

Atherosclerosis. 2008 Feb;196(2):667-73. Epub 2007 Sep 4.

14.

Genotype-by-diet effects on co-variation in Lp-PLA2 activity and LDL-cholesterol concentration in baboons fed an atherogenic diet.

Vinson A, Mahaney MC, Diego VP, Cox LA, Rogers J, VandeBerg JL, Rainwater DL.

J Lipid Res. 2008 Jun;49(6):1295-302. doi: 10.1194/jlr.M800020-JLR200. Epub 2008 Mar 11.

15.

Racial variation in lipoprotein-associated phospholipase A₂ in older adults.

Lee KK, Fortmann SP, Varady A, Fair JM, Go AS, Quertermous T, Hlatky MA, Iribarren C.

BMC Cardiovasc Disord. 2011 Jun 29;11:38. doi: 10.1186/1471-2261-11-38.

16.

Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.

Furberg CD, Nelson JJ, Solomon C, Cushman M, Jenny NS, Psaty BM.

J Am Geriatr Soc. 2008 May;56(5):792-9. doi: 10.1111/j.1532-5415.2008.01667.x. Epub 2008 Mar 21.

PMID:
18363676
17.

Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study.

Tselepis AD, Panagiotakos DB, Pitsavos C, Tellis CC, Chrysohoou C, Stefanadis C.

Atherosclerosis. 2009 Sep;206(1):303-8. doi: 10.1016/j.atherosclerosis.2009.02.016. Epub 2009 Feb 21.

PMID:
19394616
18.

Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.

Heart Protection Study Collaborative Group.

J Intern Med. 2010 Oct;268(4):348-58. doi: 10.1111/j.1365-2796.2010.02258.x.

19.

Lp-PLA2, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease.

Manichaikul A, Wang XQ, Li L, Erdmann J, Lettre G, Bis JC, Waterworth D, Cushman M, Jenny NS, Post WS, Palmas W, Tsai MY, Wallentin L, White H, Schunkert H, O'Donnell CJ, Herrington DM, Rich SS, O'Donoghue ML, Rodriguez A.

PLoS One. 2018 Oct 5;13(10):e0204352. doi: 10.1371/journal.pone.0204352. eCollection 2018.

20.

The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.

Noto H, Chitkara P, Raskin P.

J Diabetes Complications. 2006 Nov-Dec;20(6):343-8.

PMID:
17070436

Supplemental Content

Support Center